pubmed-article:19574726 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19574726 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
pubmed-article:19574726 | lifeskim:mentions | umls-concept:C1280551 | lld:lifeskim |
pubmed-article:19574726 | lifeskim:mentions | umls-concept:C0018792 | lld:lifeskim |
pubmed-article:19574726 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
pubmed-article:19574726 | lifeskim:mentions | umls-concept:C0004245 | lld:lifeskim |
pubmed-article:19574726 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:19574726 | lifeskim:mentions | umls-concept:C0991556 | lld:lifeskim |
pubmed-article:19574726 | lifeskim:mentions | umls-concept:C0164155 | lld:lifeskim |
pubmed-article:19574726 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
pubmed-article:19574726 | lifeskim:mentions | umls-concept:C0521115 | lld:lifeskim |
pubmed-article:19574726 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:19574726 | pubmed:dateCreated | 2009-7-17 | lld:pubmed |
pubmed-article:19574726 | pubmed:abstractText | Pharmacokinetics of pilsicainide transdermal patch and its electropharmacological effects were simultaneously assessed using chronic atrioventricular block dogs. After application of the patch (9.8 mg/kg), pilsicainide was continuously absorbed through the skin with a C(max) of 0.49 +/- 0.13 microg/ml, while its plasma concentration was kept above the clinically reported minimum effective plasma concentration for 2 - 8 h. Inter-atrial conduction time was significantly prolonged, whereas statistically significant prolongation was not detected in the atrial effective refractory period. Prolongation of the cycle length of atrial fibrillation and anti-fibrillatory action were confirmed. Thus, pilsicainide can be absorbed transdermally to exert long-lasting electropharmacological effects leading to anti-atrial fibrillatory action. | lld:pubmed |
pubmed-article:19574726 | pubmed:language | eng | lld:pubmed |
pubmed-article:19574726 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19574726 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19574726 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19574726 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19574726 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19574726 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19574726 | pubmed:month | Jul | lld:pubmed |
pubmed-article:19574726 | pubmed:issn | 1347-8613 | lld:pubmed |
pubmed-article:19574726 | pubmed:author | pubmed-author:TakaharaAkira... | lld:pubmed |
pubmed-article:19574726 | pubmed:author | pubmed-author:IwasakiHirosh... | lld:pubmed |
pubmed-article:19574726 | pubmed:author | pubmed-author:NakamuraYujiY | lld:pubmed |
pubmed-article:19574726 | pubmed:author | pubmed-author:NagaiTakeshiT | lld:pubmed |
pubmed-article:19574726 | pubmed:author | pubmed-author:SugiyamaAtsus... | lld:pubmed |
pubmed-article:19574726 | pubmed:author | pubmed-author:SatohYoshioki... | lld:pubmed |
pubmed-article:19574726 | pubmed:author | pubmed-author:ShinkaiNorihi... | lld:pubmed |
pubmed-article:19574726 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:19574726 | pubmed:volume | 110 | lld:pubmed |
pubmed-article:19574726 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19574726 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19574726 | pubmed:pagination | 410-4 | lld:pubmed |
pubmed-article:19574726 | pubmed:meshHeading | pubmed-meshheading:19574726... | lld:pubmed |
pubmed-article:19574726 | pubmed:meshHeading | pubmed-meshheading:19574726... | lld:pubmed |
pubmed-article:19574726 | pubmed:meshHeading | pubmed-meshheading:19574726... | lld:pubmed |
pubmed-article:19574726 | pubmed:meshHeading | pubmed-meshheading:19574726... | lld:pubmed |
pubmed-article:19574726 | pubmed:meshHeading | pubmed-meshheading:19574726... | lld:pubmed |
pubmed-article:19574726 | pubmed:meshHeading | pubmed-meshheading:19574726... | lld:pubmed |
pubmed-article:19574726 | pubmed:meshHeading | pubmed-meshheading:19574726... | lld:pubmed |
pubmed-article:19574726 | pubmed:meshHeading | pubmed-meshheading:19574726... | lld:pubmed |
pubmed-article:19574726 | pubmed:meshHeading | pubmed-meshheading:19574726... | lld:pubmed |
pubmed-article:19574726 | pubmed:meshHeading | pubmed-meshheading:19574726... | lld:pubmed |
pubmed-article:19574726 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19574726 | pubmed:articleTitle | Simultaneous assessment of pharmacokinetics of pilsicainide transdermal patch and its electropharmacological effects on atria of chronic atrioventricular block dogs. | lld:pubmed |
pubmed-article:19574726 | pubmed:affiliation | Department of Pharmacology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Yamanashi, Japan. | lld:pubmed |
pubmed-article:19574726 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19574726 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |